Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Baxter International (NY: BAX )

75.19 +1.29 (+1.75%)
Official Closing Price Updated: 7:00 PM EDT, May 25, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,049,981
Open 73.83
Bid (Size) 73.90 (1)
Ask (Size) 76.10 (1)
Prev. Close 73.90
Today's Range 73.54 - 77.08
52wk Range 69.72 - 89.70
Shares Outstanding 499,910,255
Dividend Yield 1.30%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Baxter Highlights Business Strategies and Innovation at 2022 Investor Conference
From Baxter International Inc.
Via Business Wire
Where Baxter Intl Stands With Analysts
Within the last quarter, Baxter Intl (NYSE:BAX) has observed the following analyst ratings: 
Via Benzinga

Performance

YTD
-13.45%
-13.45%
1 Month
+3.13%
+3.13%
3 Month
-12.30%
-12.30%
6 Month
-3.13%
-3.13%
1 Year
-8.69%
-8.69%

More News

Read More
Baxter to Host 2022 Investor Conference
From Baxter International Inc.
Via Business Wire
7 Defensive Dividend Healthcare Stocks to Buy Now
Via InvestorPlace
Analyst Ratings for Baxter Intl
Via Benzinga
Recap: Baxter Intl Q1 Earnings
Via Benzinga
Baxter International's Return on Invested Capital Overview
Via Benzinga
Baxter Increases Dividend and Declares Quarterly Dividend
From Baxter International Inc.
Via Business Wire
Baxter's FDA Review For Novum IQ Large Volume Pump Put On Hold, Lowers FY22 EPS Outlook
Via Benzinga
Baxter Reports First-Quarter 2022 Results
From Baxter International Inc.
Via Business Wire
Earnings Outlook For Baxter International
Via Benzinga
Death Cross Looms Over Baxter Intl Investors
Via Benzinga
Baxter Highlights New Data at SCCM Critical Care Congress Showing Hemodynamic Monitoring May Help Predict Patient Outcomes
From Baxter International Inc.
Via Business Wire
Baxter Announces U.S. FDA Clearance of ST Set Used to Help Treat Acute Kidney Injury Patients in the Hospital
From Baxter International Inc.
Via Business Wire
Why Savvy Investors Look For 'Ports In Storms' Like Agilent, Thermo Fisher And Others
Via Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For April 4, 2022
Via Benzinga
10 Biggest Price Target Changes For Monday
Via Benzinga
Ten Healthcare Companies With High Payout Ratio
Via Talk Markets
Baxter to Host First-Quarter 2022 Financial Results Conference Call for Investors
From Baxter International Inc.
Via Business Wire
FDA Issues To Class I Recall To Baxter's Spectrum Infusion Pump
Via Benzinga
Boston Scientific Stock Earns Relative Strength Rating Upgrade; Hits Key Threshold
Via Investor's Business Daily
Baxter Expands Cybersecurity Commitment, Joins Forces With U.S. Cybersecurity and Infrastructure Security Agency (CISA) Led Program
From Baxter International Inc.
Via Business Wire
Baxter to Present at the Raymond James 43rd Annual Institutional Investors Conference
From Baxter International Inc.
Via Business Wire
Analyst Ratings For Baxter Intl
Via Benzinga
Baxter Clocks Better-Than-Expected Q4 Earnings, But FY22 Guidance Trail Street View
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.